Efficacy and Safety of Dupilumab in Children With Moderate‐to‐Severe Asthma: A Systematic Review of Emerging Phase 3 Evidence

Documenti analoghi

• Plastic Bronchitis—A Promising Intervention for a Challenging Condition
  di: Wedad Alhazmi, et al.
  Pubblicazione: (2024)
• Dupilumab Plus Medium‐Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High‐Dose ICS in Children With Uncontrolled Moderate‐to‐Severe Type 2 Asthma
  di: Leonard B. Bacharier, et al.
  Pubblicazione: (2025)
• Cost‐Effectiveness Analysis of Omalizumab Combined With Standard of Care in Treating Moderate to Severe Asthma Children in China
  di: Wang Cao, et al.
  Pubblicazione: (2025)
• Remission in Children Receiving Biologic Therapy for Severe Asthma
  di: Eilidh Bruce, et al.
  Pubblicazione: (2025)
• The Role of Vitamin D in Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta‐Analysis
  di: Joelia M. Ladeira, et al.
  Pubblicazione: (2026)